Amsterdam et al. examined LGR5 expression using IHC in normal ovaries, borderline tumors, and serous carcinomas and reported that LGR5 expression was present in normal OSE, but not in ovarian tumors21. Here, LGR5 is linked to serous adenocarcinoma.